Citace podle APA (7th ed.)

(15206898), H. J. J., (15053070), G. H., (15206901), A. W. M., (15206904), Z. M., (15019395), E. A. R., (15206907), T. H., . . . (15044781), E. R. P. (2025). Supplementary Tables 1 from A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy.

Citace podle Chicago (17th ed.)

(15206898), H. Josh Jang, et al. Supplementary Tables 1 from A Phase II Trial of Guadecitabine Plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing After Initial Immune Checkpoint Inhibitor Therapy. 2025.

Citace podle MLA (9th ed.)

(15206898), H. Josh Jang, et al. Supplementary Tables 1 from A Phase II Trial of Guadecitabine Plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing After Initial Immune Checkpoint Inhibitor Therapy. 2025.

Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..